Radiolabelled monoclonal antibodies recognizing CD20 or CD37 surface markers on B-cells data

Antibodies provided by IDPH, Bristol-Myers, and Coulter were tested as vehicles for delivery of high doses of radiation to tumors in a patient population that is typically unresponsive.

According to the report in the New England Journal of Medicine, complete responses were achieved in 16 of 19 patients, with nine patients remaining